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Abstract

Introduction

When blood contacts the surface of a material, several processes take place including the activation of coagulation and immune systems. The aim of this work is
to study in vitro the biological reactions seen from the
point of view ofhemocompatibility and cytocompatibility
of a new polymer suggested as an artificial surface for
cardiovascular applications: CarbofiJm® coated polyetherimide (C®PEI) in comparison to polyetherimide
(PEl), the uncoated form . PEl and C®PEI showed no
signs of acute cytotoxicity although following long term
incubation with PEl cytotoxicity was somewhat increased; both materials supported good endothelial cell
adhesion with a higher level of cell proliferation on the
coated form. No significant difference was detected in
the activation of the inflammatory response and in
thrombogenicity tested by assay of prostaglandin E2
(PGE2) and tromboxane B2 (TXB2) respectively, following incubation of the biomaterials with platelet-rich
plasma (PRP). Complement activation assessed by sodium dodecy! sulfate - polyacrylamide gel electrophoresis
(SDS-PAGE)/Westem Blot analysis of both contacting
plasma and protein which adsorbed on the surface of the
polymers showed both materials to be activators of complement. In conclusion, Carbofilm® coating, showing
lower cytotoxic activity and higher endothelial cell
growth in comparison with uncoated material, seems to
increase PEl compatibility.

The use of synthetic materillls for biomedical devices has increased considerably in "reeent years with the
availability of new polymers having appropriate mechanical and physical properties for specific clinical applications (Remes and Williams, 1992).' These applications
depend on the complexity of biological reactions 'that
occur at the interface between tis sues and · implant
(Peluso et al., 1994). To date, no synthetic material
developed is entirely passive to blood. When blood
contacts the surface of a material, several processes such
as the activation of both coagulation and iriunune systems take place in order to protect the host agaiiist ~ not
self' components (Woffmdin and Hoenich, 1988}. •Several humoral and cellular factors are recruited by a complex mechanism resulting· in the reeognition of foreign
surfaces by the host (Montdargent et al., 1992). Among
these, the activation of the complement system is an
important event resulting in the production of proteolytic
fragments which are then recognized by different leukocyte subsets through specific receptors thus initia:ting the
cell-mediated inflammatory response (Kaz.atchkine and
Carreno, 1988; Labarre et al., 1993). Platelet adhesion
and secretion of intracellular components· constitUte
another consequence of the contact of blood with foreign
material surface (Kottke-Marchant et al. , 1989). Moreover platelets catalyze the interactions among plasma
coagulation proteins, leading to thrombin formation
(Leake et al., 1989).
One of the most promising approaches to reducing
the thrombogenicity of the blood contacting surface of
synthetic polymers is to coat the surface with endothelial
cells (ECs). Attempts were made either by seeding the
polymer surface with low numbers of ECs at surgery
and allowing gradual growth to confluence in vivo
(Ortenwall et al., 1988) or by sodding at high densities
to produce a cell coated: graft at implantation (Jarrell et
' ''\J,
al., 1986).
It is generally accepted; that the physicochemical
composition of the substrate is a key determinant in the
amount and confqrmation of adsorbed cell adhesion pro-
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ried out, to evaluate the acute cytotoxicity of the chemicals that could be released by the test materials into the
culture medium. Evaluation was performed by neutral
red vital stain (1 hour of exposure) uptake test {American Society for Test.ing of Materials (ASTM), 1985} and
also by lactate dehydrogenase (LDH) concentration test
on a monolayer of murine fibroblasts 3T3 (ATCC CRL
1658; American Type Culture Collection, Rockville,
MD) cultured in Dulbecco's modified Eagle's medium
(DMEM, Sigma, St. Louis, MO) supplemented with
10% (v/v) fetal bovine serum (FBS, Sigma), penicillin
(100 U ml- 1), streptomycin (100 g rnl- 1) and 0.03%
(v/v) L-glutamine. LDH is an enzyme released from the
cell when the cell membrane is ruptured so the amount
of LDH present in the media at the completion of the
test correlates with the amount of cell death in the culture. In a 24-well plate, 1. 3 x 104 cells/ cm2 were added
onto the surface of PEl and C®PEI in triplicate; two additional cultures were used as negative controls and two
others were treated with Triton X-100 providing positive
controls for LDH analysis. After a 96 hour incubation,
LDH activity (Sigma Kit) was measured at 340 nm, corresponding to the oxidation of NADH to NAD+ in the
presence of LDH and pyruvate.
To mimic the long-term effects of the body environment on the biomaterials, extracts were prepared in
phosphate-buffered saline (PBS) , corresponding to a surface area of 1 cm 2 /rnl, at 60°C for 10 days (artificial
ageing extract) according to ASTM (1985) guidelines.
The extracts were tested by the microculture tetrazolium
assay using 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide (MTT assay). The assay is based
on the observation that viable cells are able to metabolize a water-soluble tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide (MTT), into
an insoluble forrnazan salt product by the action of mitochondrial succinate dehydrogenase (Kirkpatrick and
Dekker, 1992; Smith et al., 1992; Dekker et al., 1994).
The extracts, obtained by maintaining the samples
for 10 days at 60°C, were diluted with growth medium,
containing double concentrated serum, to a ratio of 1:4.
The dilution was added to the cell cultures; medium
obtained in the same way without addition of polymers,
provided the negative control, while 2% (v/v) dimethylsulfoxide (DMSO) in growth medium was used as positive control because of its inhibitory action on cell
viability (Ignatius and Claes, 1995).
NIH 3T3 cells (8 x 1o3/well) were plated into 96
well microtitre plates; after 6 hours plating, the growth
medium was replaced by 200 J.d/well of diluted extracts.
At least six replicates were prepared for each material
and for positive and negative controls. The cells were
exposed to the extracts for 4, 24, 48 hours at 37°C in a
5% C0 2 atmosphere. Then, 10 J.!l per well of an MTT

teins which mediate cell adhesion (Ratner, 1993). Besides fibronectin and extracellular matrix coating, pyrolytic carbon is widely used in prosthetic devices that
come into contact with blood (Pacagnella et al., 1986).
Since pyrolytic carbon is one of the best artificial materials currently available in terms of chemical inertness
and absence of thrombogenic reactions (Aebischer et al.,
1988), the aim of this work is to study, in vitro, the biological reactions, seen from the point of view of hemocompatibility and cytocompatibility of a new polymer
proposed for cardiovascular application, that is, Carbofilm® coated Polyetherimide (C®PEI) in comparison with
the uncoated form.

Materials and Methods
Biomaterials
Polyetherimide (C 38 H 25 0 6 N2,)n (PEl, Litrex I;
Petrochemie Danubia GmbH, Mannsworth, Austria) is
a thermoplastic amorphous polymer with a glass transition temperature of about 217 °C. The poly-(etherimide)
resin is the latest synthesized polyimide (General Electric Co., Mt. Vernon, IN) and probably represents the
most successful combination of polyimide performance
and processability. This polymer is synthesized by reaction of dianhydrides containing ether links and diamines;
the polyetherimide is characterized by high strength,
rigidity and dimensional stability and good electrical
insulation properties, which are largely maintained after
prolonged exposure to temperatures up to about 180°C.
This polymer is resistant to a wide range of solvents
including alcohols and fully halogenated compounds.
Carbofi]m® coated Polyetherimide (C®PEI, furnished by Tecnobiomedica, Rome, Italy) is made of the
same material, PEl, modified by a pyrolytic carbon coating obtained by a physical vapor deposition (PVD) process, similar to that employed for valve prostheses. This
technique is performed in a high vacuum and the transfer is obtained by bombarding the target with an ion
beam at 40-200°C range (Pacagnella et al., 1986).
Medical grade Silicone (Perthese® LP 502-1, Laboratoire Perouse Implant, Borne!, France) and glass
(microscope slide glass) were used as controls for hemocompatibility and cytocompatibility assessment.
All samples were squares of 1 em x 0.5 em, provided with siliconized edges to avoid direct contact of the
material with the medium. The sterilization procedures
were performed according to manufacturers' specifications: after three washes of 30 minutes each in distilled
water and in 0.9% (volume/volume, v/v) NaCl solution,
the materials were autoclaved at 121 °C for 20 minutes.

Cytotoxicity evaluation
An in vitro screening test on cell cultures was car118
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solution (5 mg.ml- 1 PBS) were added and the plate was
incubated for 4 hours. The medium was removed and
the formazan crystals dissolved in dimethylsulfoxide
(DMSO). The colorimetric staining was then evaluated
on a multiwell plate reader (450 Microplate Reader,
BioRad, Richmond, CA) at 540 nm.

0.5 em of PEl, C®PEI, silicone and glass as negative
and positive control respectively (n = 16) . The plate
was then rotated for 30 minutes at room temperature for
the contact between PRP and biomaterials. After the
contact period, a platelet activity inhibiting solution,
made of ethylene diarninotetracetic acid (EDT A) and indomethacin, was added to PRP specimens in the ratio of
10 parts of PRP and 1 part of solution. The PRP specimens were purified by solid/liquid extraction using
Amprep minicolumns (Amersham International pic,
Amersham, UK) before assaying arachidonic acid
products.
The concentrations of Prostaglandin E2
(PGE2) and Tromboxane B2 (TXB2) were determined
with enzyme immunoassay (EIA) using PGE2 EIA Kit
(Cayman Chemical Company, Ann Arbor , MI) and
TXB2 EIA system (Amersham) respectively. Results
are expressed as pg/rnl .
Complement activation was studied through the
analysis of complement components bound on the surface. A sample of PRP was inactivated by heating at
60°C for 30 minutes and used as additional control together with a sample of PRP inactivated with EDT A.
Squares of biomaterials were incubated with plasma for
1 hour at room temperature. After removal of plasma,
squares were washed four times in PBS . The squares
were then transferred into Eppendorf tubes and incubated at 90 °C for 10 minutes in a 2% (w/v) sodium dodecyl sulfate (SDS). Samples were analyzed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Laemrnli (1970) and the gel was
stained with a Silver Stain kit (BioRad). Western blot
was performed using polyclonal anti-C3 antibody
(DAKO) followed by horseradish peroxidase conjugated
antibody. ECL Western blotting detection reagents
(Amersham) were used for revelation.

Adhesion and proliferation test
Endothelial cells were obtained by isolation from
human umbilical cord vein (HUVEC), collected from
Caesarean deliveries according to the method described
by Jaffe et al. (1973). Cells were cultured in tissue-culture grade polystyrene plates (Corning, Cambridge, MA)
precoated with a 0.5% (v/v) gelatin (Sigma) solution in
complete medium composed of M199 (Sigma) supplemented with 20% (v/v) FBS (Sigma), heparin (50 U/ml
Sigma), 300 ;.tg/ml endothelial cell growth supplement,
produced according to Maciag et al. (1979), 0.03%
(v/v) L-glutamine (Gibco, Paisley , UK), 100 U/ml penicillin and 100 ;.tglml streptomycin (Sigma) . Cells used
for the experiments were between 2nd and 5th passage
after the confluency of the culture.
Human umbilical vein endothelial cells were identified by immunofluorescent staining for von Willebrand
factor (DAKO, Glostrup , Denmark) . Briefly, after fixing with 3% (v/v) paraformaldehyde, endothelial cells
were rinsed with phosphate buffered saline (PBS), permeabilized with 0.1% (v/v) Triton X-100 (1 minute)
rinsed with PBS, incubated with primary antibody and
stained with fluorescent goat anti-rabbit IgG. Negative
controls were human fibroblasts (MRC5 cell line) and
HUVEC not coated with primary antibody .
HUVEC were placed on the biomaterial surface at
5 x 1oJ cells/cm2 in a 24 microplate well. Adhesion
and proliferation tests were performed after 6 hours and
5 days, respectively. The materials, after rinsing in
PBS, were fixed 2b minutes at 60°C and stained with a
0.025% (weight/volume, w/v) Acridine Orange solution,
a nucleic acid staining dye (Kepner and Pratt, 1994).
Cell number on each material was performed using a
fluorescence microscope (Aristoplan; Leitz, Milano,
Italy) and results are expressed as percent cell number
with respect to plated cells (5 x 1o3 cells/cm2),
considered as 100%.

Statistical analysis
Statistical analysis of the data was carried out using
a PC-compatible equipped with SPSS for Windows software. Bonferroni evaluation was performed to compare
cytotoxicity, adhesion and proliferation results ; p value
was obtained from the analysis of variance (ANOV A)
table. The conventional 0.05 level was considered to
reflect statistical significance.

Hemocompatibility evaluation
Results

Platelet rich plasma (PRP) was prepared using
pooled venous blood from healthy donors collected in
siliconized tubes containing 3.5% (w/v) sodium citrate
as anticoagulant. PRP was obtained by centrifugation at
500 x g for 10 minutes at 4 °C. Before using, it was
analyzed using a flow cytofluorimeter (Becton Dickinson, Meylan, France) to evaluate the cellular population.
PRP ( 1. 8 ml) was added to each well of a 24-well
microtitre plate (Coming) containing squares of 1 em x

Cytotoxicity evaluation
Fibroblasts in contact with PEI and C®PEI showed
no sign of damage such as morphological elongation,
loss of neutral red, pycnotic nuclei , etc. . In contrast ,
cells cultured in contact with Triton X-100 (positive control) were scanty, rounded and had lost the vital stain
(results not shown). These results were confirmed by
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Table 1. MTI test expressed as negative control (in %)*.
4 hours

Materials
PEl

68.66

Carbofilm PEl

68.45

Positive Control**

46.74

± 6.97
± 5.48
± 3.11

24 hours

48 hours

73 .78 ± 9.16

43.12 ± 3.22

± 6.71
± 2.16

52.37 ± 13.07

70.43
37 .39

23.55

±

1.42

Relative MTT formazan formation by NIH 3T3 cells after incubation with extracts of the materials studied for 4 , 24,
48 hours. The formazan formation is expressed as a percentage of the amount produced by cell s incubated with fresh
culture medium (means ± standard deviation of six replicates) . Dilution factors of the primary extract = 4X.
* Negative control: Cells without polymer extracts in the culture medium.
** Positive control: Cells with 2% DMSO in the growth medium.

Table 2. Cytocompatibility results.
Carbofilm PEl
Cell Growth* (%)

453 . 14

± 84.00

386 .37

Adhesion**(%)

77 .37

± 13 .70

70.15

± 70.00

±

Glass

Silicone

PEl

10.90

121.80

± 40.60

54.28

± 5.00

219.42

± 83.00

75.24 ± 12.00

* Day 5 cell count/plating cell density xlOO.
** Cell count at 6 hours incubation/plating cell density xlOO.
The materials with cells on the luminal surface were stained with Acridine Orange solution and cells were quantified
using a fluorescent microscope. n = 4; values are mean ± standard deviation.
PEl

=

polyetherirnide;

CarbofilmPEI = Carbofilm coated polyetherimide.

Table 3. Arachidonic acid metaboli sm.
Carbofilm PEl
PGE2 (pg/ml)
TXB2 (pg/ml)

58 .94 ±
290.75

±

Silicone

PEl

8.20

56.08

111.50

209 . 10

±

Glass

6.70

51.25 ± 9.20

± 53 .50

242.50 ± 49.30

67.70

±

6.40

299.30 ± 124.50

Arachidonic acid metabolites enzyme immunoassay results at 30 minutes contact between platelet rich plasma and
biomaterials.
n

=

16; values are mean ± standard deviation.

Results are expressed as pg/ml .

LDH release assessment (Fig. 1) as a method for the
evaluation of the cell membrane integrity .
MTI test results are expressed in Table 1 where the
absorbance results showed the percentage of cell growth
in relation to the negative control. Formazan salt production was significantly different between cells treated
with DMSO (positive control) and both test materials at
each incubation time. Both materials revealed a decrease in formazan salt production measured at 48 hours

incubation in comparison with 4 and 24 hour incubation
periods. This decrease was significant only for PEl
(Bonferroni test with a = 0.05).

Cytocom pati bili ty
All surfaces showed great endothelial cell attachment with a significantly lower cell adhesion on silicone
than on the other materials tested; no significant differences in adhesion were noted between PEl, C®PEI and
120
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F igure 1. Results provided by assessment of cell membrane damage, are expressed as LDH activity (U/1) ±
standard deviation at 340 nm.
glass although C®PEI supported the highest number of
adherent cells (Bonferroni test with significance level
0.05). There was signi ficantly more cell growth on PEl
and C®PEI (p < 0.05) than on glass (positive control)
or silicone; among all samples, C®PEl showed the
greatest cell growth (Table 2).

29--

1

Hemocompatibility
Arachidonic acid metabolite results are shown in Table 3. No significant differences in TXB2 concentration
were observed among materials and values decreased as
follows: glass, C®PEI, silicone, and PEL PGE2 levels
were higher in plasma which had contacted glass and no
difference was revealed between the other materials.
The SDS-PAGE electrophoresis of proteins present
on the surface of biomaterials, incubated with platelet
rich plasma, is presented in Figure 2a. The predominant
protein on all surfaces had molecular weight from 29 to
51 KDa. The surface of C®PEI appeared to have the
least adsorbed protein.
The immunoblot, incubated with polyclonal anti-C3
antibody, showed C3 fragments both on the surface of
every biomaterial and in the plasma after contact with
the materials (Fig. 2b). The predominant polypeptides
had molecular weights of - 70 KDa, and - 40 KDa,
representing the /3-chain of C3/C3b and fragments of
iC3b respectively. These two bands )lave been found in
the control PRP, in the incubation plasma used for the
complement activation test and, at higher concentration,
bound on the surface of the four materials. In Figure
2b, bands near 200 KDa, 120 KDa and 29 KDa were
visible only for the biomaterials eluted proteins (lanes 2 ,
3, 4, and 5) and represented C3, a-chain of C3/C3b,
and fragments of C3c, respectively. Generally, we have

2

-

3 4 5

6

Figure 2. (a) . SDS-PAGE patterns of protein layers
adhered to biomaterials, after in vitro incubation with
platelet rich plasma (PRP): (1) CarbofilmPEl, (2) PEl,
(3) Glass , (4) Silicone, (5) Molecular Weight, (6)
Control (PRP) . (b). lmmunoblot of C3 fragments
present on the surface of biomaterials incubated with
PRP. Lane 1: control PRP; Lane 2: CarbofilmPEl;
Lane 3: PEl; Lane 4: Silicone; Lane 5: Glass; Lane 6:
PRP after contact with CarbofilmPEl; Lane 7: PRP after
contact with PEl; Lane 8: PRP after contact with
silicone; Lane 9: PRP after contact with glass.
observed a reduced intensity band at 29 KDa and 75
KDa for silicone, and at 120 KDa and 70 KDa for glass
compared to the other materials.

Discussion
To date, no synthetic material developed is entirely
passive to blood. In particular, polymer surfaces developed for cardiovascular application cause platelet adhesion, followed by platelet release and aggregation. In
addition, polymers are also able to stimulate coagulation,
complement activation and leukocyte adhesion (KottkeMarchant et al., 1989).
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four materials considered: the higher result was for the
positive control material, glass, and the lower value for
the negative control material, silicone, while PEl and
C'8 PEI were quite similar for PGE2 and TXB2 levels.
C®PEI induced a TXB2 production not significantly
higher than the values induced by PEl, indicating only
a slightly higher activity on platelet aggregation.
In conclusion, on the basis of our results, neither
material gave any sign of acute cytotoxicity and, at" long
term incubation, PEl was less biocompatible exhibiting
lower cell vitality. No significant difference was detected in the activation of the inflammatory response or in
complement activation. In addition the ability of endothelial cells to form a monolayer and to proliferate on
both the materials was shown to be good and C®PEI
showed higher endothelial cell growth, a sign of better
endothelialization. Therefore, Carbofilm® coating of
PEl seems to increase material biocompatibility when
compared to uncoated PEl that itself is an excellent biocompatible material (Peluso et al. , 1994). The improvement of cytocompatibility and hemocompatibility of the
coated material, however, needs more experiments to
relate the obtained results, for example, to dynamic tests
which approach in vivo conditions.

Endothelial cells play a key role in the development
and dissolution of thrombi, producing factors such as
urokinase-type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor-!,
platelet activating factor, prostacyclin, and nitric oxide
(Vanhoutte, 1989). Attempts to form a complete endothelial cell layer on synthetic graft surfaces of smalldiameter vascular prostheses have been made in order to
overcome the thrombogenic properties of the exposed
surface (Zhang et al. , 1995; Burmeister et al., 1996;
Poole-Warren et al., 1996). With this in mind, the ability of endothelial cells to form a monolayer and to proliferate on a material, that was to be used for cardiovascular application, became an important and interesting parameter to study together with blood compatibility
tests.
The aim of this work was to evaluate, in vitro, the
biocompatibility of a new material, C'8 PEI in comparison with PEL Cytotoxicity screening showed that both
materials exerted no acute toxic effect on cultured fibroblasts as all the cultures showed a morphological appearance and LDH levels similar to that of negative control.
The MTI test (demonstrating not only membrane integrity, but also intracellular mitochondrial succinate dehydrogenase activity) revealed a decrease in formazan production, an index of a toxic effect, for both the materials
after a longer incubation period and this was particularly
evident for PEL
As complement activation plays an important role in
the activation of leukocytes (Labarre et al., 1993), the
complement-activation induced by the materials has to be
evaluated as part of its biocompatibility. Since deposition of C3b is believed to be the initiating event for efficient complement activation, a surface that does not bind
C3b is expected to be a poor activator (Cheung et al.,
1990; Lin et al., 1992). C3 deposition at the surface
and C3 assay to detect the degree of complement activation in serum, that had been in contact with the surface
of the materials, revealed that all the biomaterials were
activators of complement. We can hypothesize that the
large accumulation of C3 on the surface (200 KDa in the
immunoblotting) was due to complement activation and
not to spontaneous adsorption of C3, because, both the
EDT A control involving heat-inactivated plasma were
negative. The different immunoblot pattern of complement C3 fragment adsorbed on the tested surfaces in
comparison with the one obtained from control plasma
allows us to confirm a complement activation, this is
also supported by the observation of fragments of iC3b
at 40 KDa from the conversion of C3b at 70 KDa present at higher concentration bound to the surface rather
than in plasma analyzed. PGE2 and TXB2 concentrations, markers of inflammatory phenomenon and platelet
aggregation, evidenced no significant difference in the

Acknowledgements
Supported by grants from the National Research
Program: (theme 29) "Materiali compositi a base organica per applicazioni ad elevata criticita di prestazioni nel
settore biomedico" line 2-1, between the University of
Torino and Tecnobiomedica s.p.a.

References
Aebischer P, Goddard MB, Sasken HF, Hunter TJ,
Galletti PM (1988) Tissue reaction to fabrics coated with
turbostratic carbon: Subcutaneous versus vascular
implants. Biomaterials 9: 80-85.
ASTM (1985) Annual Book of ASTM Standards,
Vol. 13.01, F619-79: Practice for extraction of medical
plastics. Am Soc Testing Materials, Philadelphia. pp
176-180.
Burmeister JS , Vrany JD , Reichert WM , Truskey
GA (1996) Effect of fibronectin amount and conformation on the strength of endothelial cell adhesion to
HEMA/EMA copolymers. J Biomed Mat Res 30: 13-22.
Cheung AK, Parker CJ, Wilcox LA, Janatova J
(1990) Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophane. Kidney Int 37: 1055-1059.
Dekker A, Panfil C, Valdor M, Pennartz G, Richter
H, Kirkpatrick CJ (1994) Quantitative methods for in
vitro cytotoxicity testing of biomaterials. Cells Mater 4:
122

Evaluation of carbofilm-coated polyetherimide
101-112.
Ignatius AA, Claes LE (1996) In vitro biocompatibility of bioresorbable polymers: Poly(L, DL-lactide)
and poly(L-lactide-coglycolide). Biomaterials 17: 831839.
Jaffe EA, Nachman RL, Becker CG, Minick CR
(1973) Culture of human endothelial cells derived from
umbilical veins. Identification by morphologic an~
immunologic criteria. J Clin Invest 52: 2745-2756.
Jarrell BE, Williams SK, Stokes G, Hubbard FA,
Carabasi RA, Koolpe E, Greener D, Pratt K, Moritz
MJ, Radomski J (1986) Use of freshly isolated capillary
endothelial cells for the immediate establishment of a
monolayer on a vascular graft at surgery. Surgery 100:
392-399.
Kazatchkine MD, Carreno MP (1988) Activation of
the complement system at the interface between blood
and artificial surfaces. Biomaterials 9: 30-35.
Kepner RL, Pratt JR (1994) The use of fluorochromes for direct enumeration of total bacteria in
environmental samples: Past and present. Microbial Rev
58: 603-615.
Kirkpatrick CJ, Dekker A (1992) Quantitative evaluation of cell interaction with biomaterials in vitro.
Biomat Tissue Interface 10: 31-41.
Kottke-Marchant K, Anderson JM, Umemura Y,
Marchant RE (1989) Effect of albumin coating on the in
vitro blood compatibility of Dacron arterial prostheses.
Biomaterials 10: 147-155.
Labarre D, Montdargent B, Carreno MP, Maillet F
(1993) Strategy for in vitro evaluation of the interactions
between biomaterials and complement system. J Appl
Biomater 4: 231-240.
Laemmli UK (1970) Cleavage of structural proteins
during the assembly of the head of bacteriophage T4.
Nature 227: 680-684.
Leake DL, Cenni E, Cavedagna D, Stea S, Ciapetti
G, Pizzoferrato A (1989) Comparative study of the Dacron® combined with various polyurethanes. Biomaterials
10: 441-444.
Lin YS, Hlady V, Janatova J (1992) Adsorption of
complement proteins on surfaces with a hydrophobicity
gradient. Biomaterials 13: 497-504.
Maciag T, CerundoloJ, Ilsley S, Kelley PR, Forand
R (1979) An endothelial cell growth factor from bovine
hypothalamus: Identification and partial characterization.
Proc Natl Acad Sci USA 76: 5674-5678.
Montdargent B, Toufik J, Carreno MP, Labarre D,
Jozefowicz M (1992) Complement activation and adsorption of protein fragments by functionalized polymer
surfaces in human serum. Biomaterials 13: 571-576.
Ortenwall P, Bylock A, Kjellstr6m BT, Risberg B
(1988) Seeding of ePTFE carotid interposition grafts in
sheep and dog: Species-dependent results. Surgery 103:

199-205.
Pacagnella A, Majni G, Ottaviani G, Arru P, Santi
M, Vallana F (1986) Properties of a new carbon film for
biomedical applications. J Art Organs 9: 127-130.
Peluso G, Petillo 0, Ambrosio L, Nicolais L (1994)
Polyetherimide as biomaterial: preliminary in vitro and
in vivo biocompatibility testing. J Mat Sci Mat Med 5:
738-742.
Poole-Warren LA, Schindhelm K, Graham AR,
Slowiaczek PR, Noble KR (1996) Performance of small
diameter synthetic vascular prostheses with confluent
autologous endothelial cell linings. J Biomed Mat Res
30: 221-229.
Ratner BD (1993) New ideas in biomaterials science
- A path to engineered biomaterials. J Biomed Mater
Res 27: 837-850.
Remes A, Williams DF (1992) Immune response in
biocompatibility. Biomaterials 13: 731-743.
Smith MD, Barbenel JC, Courtney JM, Grant MH
(1992) Novel quantitative methods for the determination
of biomaterials cytotoxicity. Int J Artif Organs 15: 191194.
Vanhoutte PM (1989) Endothelium and control of
vascular function. Hypertension 13: 658-667 .
Woffindin C, Hoenich NA (1988) Blood-membrane
interactions during haemodialysis with cellulose and
synthetic membranes. Biomaterials 9: 53-57.
Zhang JC, Wojta J, Binder BR (1995) Growth and
fibrinolytic parameters of human umbilical vein endothelial · cells seeded onto cardiovascular grafts. J Thorac
Cardiovasc Surg 109: 1059-1065.

Discussion with Reviewers
G. Laroche: It is not clear in my mind that the technique that is described as being used to coat the polyimide surface is PVD. Indeed, physical vapor deposition
consists in vaporizing a coating substance on a substrate
under vacuum. Most of the time, the coating media is
heated, therefore, allowing its deposition onto the surface. However, coatings deposited in such a manner
give rise to poor adhesion as the vaporized species do
not have enough energy to be efficiently anchored onto
the surface. To my point of view, the technique that is
described by the authors (bombardment of a target with
an ion beam) actually refers to sputtering deposition.
This latter technique allows a better adhesion between
the coating and the substrate as the coating molecules
reach the surface with more energy.
Authors: We confirm that the technique used to coat
the polyetherimide surface is a PVD process involving
mass transfer from a pyrolytic carbon target to the
substrates under high vacuum. The CarbofiJm® adhesion
properties, turbostratic structure and impurity content
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the materials had no effect on lysosomal integrity
(neutral red assay) or membrane integrity (LDH) assay),
and supported enhanced cell proliferation.
Please
comment.
Authors: There is a misunderstanding regarding the
methods to prepare material extracts for MTT assay :
only serum is double-concentrated in the medium for
dilution of the extracts. MTT results on biomaterial
extracts should not be compared to neutral red, LDH
and cell proliferation studies. MIT gives us information
about long-term cytotoxicity, while the other methods
evaluate acute cytotoxicity (neutral red and LDH) and
cytocompatibility (proliferation).

have been reported by Paccagnella et al. (1986).

S.J. Northup: Based on the physical properties ofPEI,
this material is more likely to be considered as a substitute for pyrolytic carbon in heart valves or other soft tissue applications that require a rigid material (e.g., injection ports). Why was pyrolytic carbon excluded from
the experiment?
Authors: In this work, we have studied if pyrolytic carbon coating lead to an increased hemocompatibility and
cytocompatibility of PEI with the aim of obtaining a
material with the physical properties of PEI and the
biocompatibility properties of pyrolytic carbon. So we
have studied pyrolytic carbon as PEI coating.

A.Dekker: Essentially, in this study the biocompatibility of two quite different materials was tested, polyetherirnide and pyrolytic carbon, respectively. The latter one
was coated on polyetherimide. Is the biological performance of the carbon coated on polyetherimide, as you
tested it, comparable with that of pyrolytic carbon coated
on other materials, as described by other authors? How
much does the substrate for the carbon coating influence
the biocompatibility of the carbon surface?
Authors: Pyrolytic carbon was used in coating of different types of implant prostheses such as dental implants, percutaneous devicP-s, tendon and tracheal replacements and, particularly, heart valve prostheses.
Recently , it has been used as coating for vascular prostheses in Teflon® and Dacron® (Sbarbati et al., 1991 ;
Cenni et al., 1995). In these studies, pyrolytic carbon
coating shows a lower thrombogenicity and enhances in
vitro endothelial cell attachment and growth when
compared with uncoated materials.

S.J. Northup: If silicone was one of the samples to be
evaluated, why was the blood collected in siliconized test
tubes?
Authors: Silicone was used as negative control for
PGE2 and TXB2 because it was described in the literature as a non-activating material on the arachidonic acid
cascade; so, to avoid contact of blood with glass or
polypropylene when preparing PRP, we preferred to use
siliconized test tubes.

S.J. Northup: Are there any qualitative or quantitative
analytical data on the chemical residues in the extract
evaluated in the MIT assay? Is the amount and identity
of residual chemicals in an extract prepared at 60°C
comparable to that found in an extract prepared at 37 °C?
Authors: We have not done a qualitative or quantitative
analytical study on the chemical residues in the material
extracts evaluated in the MIT assay. ASTM (1985)
Guidelines were followed to study long-term effects of
the body environments on biomaterials cytotoxicity.

S.J. Northup: Please comment on the risk of adverse
health effects from circulating activated complement and
activated complement that is bound to a material.
Authors: Complement activation has many clinical
consequences on adverse health effects that correlate
with production and release of inflammatory mediators,
e.g. , leukopenia and hypoxia associated with
hemodialysis (Woffindin and Hoenich, 1988) and lung
injury after cardiopulmonary bypass (Gillinov et al.,
1993).
The immobilized C3 on polymer surface can, most
probably, function as receptors, e.g., neutrophils, potentially producing a local reaction, chemotaxis, increased
vascular permeability, and vasodilatation. We believe
that the absence of detectable C3 deposition on the
surface does not exclude active complement products
formed in the fluid in contact with the surface (Liu and
Elwing, 1994) so that both the fluid phase activation and
C3b binding to an activating surface are studied to
evaluate biomaterial complement activation.

A. Dekker: The general conclusion of the MIT test is
that cells in contact with extracts of the biomaterials
tested formed less formazan salts than the cells incubated
with fresh culture medium. In contrast, endothelial cells
grew well on the biomaterials, without signs of cytotoxicity. This contrast is not surprising, since the osmolality of the diluted extracts is likely to be too high. Namely, the extracts of the biomaterials in PBS were diluted
1:4 with double concentrated culture medium, which
contains twice the physiological salt concentration. PBS
contains a physiological salt concentration. Therefore,
the diluted extract will possess a salt concentration that
is considerably higher than the physiological one. Such
high osmolalities will impede cell growth. The usage of
normal concentrated culture medium for dilution of the
extracts would solve this problem. Please comment.
S.J. Northup : It is remarkable that an extract of PEI
and C™PEI disrupted mitochondrial metabolism, yet
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Evaluation of carbofilm-coated polyetherimide
L.A. Culp: Regarding Figure 2b, how do the authors
know that the respective bands on their gels can be
defmitively identified as C3 and C3 fragments? Another
disturbing point about Figure 2b is the relative underloading of protein in Janes 6-9 compared to Janes 2-5;
perhaps C3 and its fragments do appear in lanes 6-9 but
the authors have not loaded a comparable amount of
total protein.
W. van Oeveren: The Results on immunoblot (Fig.
2b) are not clear. Is Figure 2b only presenting proteins
bound to the biomaterial surface, or is lane 6-9 presenting the C3 fragments in serum? An important conclusion from these qualitative complement tests could be
that despite reduced protein binding to carbofilm, complement binding and activation is high, indicating poor
biocompatibility to this aspect.
Authors: We have identified C3 and C3 fragments
bands in the blot incubated with anti-C3 antibodies based
on molecular weights (Berger et al., 1994). In Figure
2b we have loaded the same amount of total protein in
Janes 2-9. Lanes 6-9 present C3 fragments in platelet
rich plasma, used as a control at a higher total protein
concentration than in lane 1; lanes 2-5 present C3
fragments eluted from the materials. The proposed
conclusion on our qualitative complement tests IS
interesting but needs more tests to be confirmed.
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L.A. Culp: The authors should state whether their
cultured 3T3 cells contained serum (type of serum?) in
the medium when tested with biomaterials. This is
critical to evaluate whether cell surface proteins are
interacting with the material directly or indirectly via
adsorbed serum proteins. The same comment applies to
culture of the endothelial cells in Materials and
Methods.
G. Laroche: Experiments on platelet and fibrinogen adhesion would have brought additional useful information
on carbon-coated polyetherimide performances.
Authors:
Our medium used to culture 3T3 and
HUVEC cells on biomaterials contained fetal bovine
serum (Sigma). In this study, we have not evaluated if
cell interaction with the material is mediated by adsorbed
serum proteins. We have only evaluated differences in
cell adhesion and proliferation between coated and uncoated material. Biomedical carbon surfaces and their
interactions with plasma proteins have been studied by
Feng and Andrade (1994a,b, 1995).
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